 |
|
|
|
|
|
|
|
|
|
|
|
1 to 10 of 10 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Calon F. on PAPER: Min SW. et al., 2010, The debate continues about which key modifications turn tau into a neuron killer. This study by... 27 Sep 2010.
|
|
|
 |
|
|
Calon F. on NEWS: Sweet 16: Novel APP Processing Pathway and a New Biomarker?, A critical question indeed. We should answer that. The evaluation of cognitive function may lack... 28 Apr 2010.
|
|
|
|
|
|
Calon F. on NEWS: Medical Foods—Fallback Option for Elusive AD Drug Status?, I think it would have been a major advantage to get Ketasyn/AC1202 FDA-approved as a drug.... 12 Nov 2009.
|
|
|
|
|
|
Calon F. on PAPER: He C. et al., 2009, This paper from He et al. adds to the mounting evidence that omega-3 polyunsaturated fatty acids... 29 Jun 2009.
|
|
|
|
|
|
Calon F. on Early-Onset Familial AD: Alzheimer Disease in Mid-life, I would like to thank Richard Bozanich for his toughtful comments. AD is often mistaken for... 22 Oct 2007.
|
|
|
|
|
|
Calon F. on SITE POLL: What's the AD drug smith to do about the blood-brain barrier?, BBB Is Overrated; Any Molecule Can Be Engineered to Get In!
Not a single drug on the... 29 Mar 2007.
|
|
|
|
|
|
Calon F, Laurin D. on PAPER: Schaefer EJ. et al., 2006, The prospective study of Ernst Schaefer et al. suggests an interesting link between blood... 6 Dec 2006.
|
|
|
|
|
|
Calon F. on NEWS: First Trial of Fish Fats Shows Promise for Early AD, To determine the efficacy of any drug, randomized clinical trials (RCTs) remain the gold... 14 Oct 2006.
|
|
|
|
|
|
Calon F. on NEWS: Omega-3 Fatty Acid Target Identified in Neurite Extension, The recent paper of Frédéric Darios and Bazbek Davletov adds up to recent studies trying to... 17 Apr 2006.
|
|
|
|
|
|
Calon F, Cole G, Frautschy S. on NEWS: Presenilins Work Overtime to Control Akt, Tau, and Aβ—n-3 Fatty Acids Aid and Abet, This report from Akbar and Kim adds to their earlier work in this area by providing compelling... 25 Jul 2005.
|
|
|
|
|
|
|
1 to 10 of 10 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
See our latest Webinar: 
